- Home
- ALEX vs KOD Comparison
ALEX vs KOD Comparison
Compare ALEX & KOD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALEX | KOD |
|---|---|---|
| Founded | 1870 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ALEX | KOD |
|---|---|---|
| Price | $20.73 | $24.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 3 | 7 |
| Target Price | $21.00 | ★ $28.29 |
| AVG Volume (30 Days) | 619.3K | ★ 854.6K |
| Earning Date | 02-26-2026 | 11-13-2025 |
| Dividend Yield | ★ 6.76% | N/A |
| EPS Growth | ★ 65.09 | N/A |
| EPS | ★ 1.01 | N/A |
| Revenue | ★ $226,062,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $2.12 | N/A |
| P/E Ratio | $20.52 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $15.07 | $1.92 |
| 52 Week High | $21.03 | $31.18 |
Technical Indicators
Market Signals| Indicator | ALEX | KOD |
|---|---|---|
| Relative Strength Index (RSI) | 69.00 | 43.67 |
| Support Level | $20.68 | $25.93 |
| Resistance Level | $20.80 | $29.49 |
| Average True Range (ATR) | 0.06 | 1.98 |
| MACD | -0.14 | -0.46 |
| Stochastic Oscillator | 34.21 | 12.77 |
Price Performance
Historical ComparisonAbout ALEX Alexander & Baldwin Inc. REIT Holding Company
Alexander & Baldwin Inc is a Hawaii commercial real estate company. The group owns, operates, and manages million square feet of retail, industrial, and office space in Hawaii. It is a real estate investment trust (REIT) and the owner of grocery and drug-anchored retail centers in the state. It functions through two segments namely Commercial Real Estate and Land Operations. The Commercial Real Estate segment owns and manages retail, industrial spaces, and also urban ground leases in Hawaii, thereby accounting for a majority of the company's revenue. The Land Operations segment actively manages the company's land and real estate-related assets and makes optimum utilization of these assets. Geographically, the activities are carried out across the United States.
About KOD Kodiak Sciences Inc
Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is BLA, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD. The pipeline products of the company include Tarcocimab tedromer, KSI-501, and KSI-101.